However, we should also mention that some evidence suggests methotrexate having positive cardiovascular effects, specifically through the activation of the adenosine monophosphate (AMP)-activated protein kinase (AMPK)/eNOS pathway, thus reducing endothelial dysfunction (88). This evidence concerns the gene NOS3 and endothelial dysfunction.